An Oura Ring (third generation) showing the sensors inside the band. The deal puts Counsel Health's doctors inside the Oura app. Image: Wikimedia Commons / Tpnkl, CC BY-SA 4.0
TL;DR — Oura Counsel Health acquisition explained: Oura has agreed to buy Counsel Health, an AI-powered primary care company, for $625 million in cash (about ₹5,900 crore). The deal, announced on 10 November 2026, turns the Oura Ring from a tracker that tells you something is wrong into a service that connects you to a doctor about it — first chatting with medical AI, then with a board-certified physician inside the Oura app. The deal is announced, not yet closed, and the doctor service is US-focused for now, so Indian ring owners will have to wait.
Key Highlights
- Oura has signed a definitive agreement to acquire Counsel Health for $625 million in cash; the deal is expected to close before the end of 2026.
- Counsel pairs medical AI with in-house physicians: members chat with the AI, then escalate to a board-certified doctor within minutes, all inside the Oura app.
- Oura reported record results alongside the deal: fiscal Q4 revenue of $533 million, up 153% year over year, and fiscal 2026 revenue of about $1.75 billion, up 92% — both preliminary and unaudited.
- Oura says it has more than 6 million members; among members who used Counsel, over 90% of those surveyed said their Oura data helped them get better care.
- For India, the hardware is here — the Oura Ring 5 launched in India at ₹39,900 in October — but Counsel's doctor service has no India availability yet.
What happened?
On Tuesday 10 November 2026, Oura announced it has entered into a definitive agreement to acquire Counsel Health, an AI-native primary care company, for $625 million in cash. The announcement came in a press release carried by Business Wire, and was confirmed the same day by Reuters and STAT.
A definitive agreement is the signed deal — but it is not the same as a done deal. Oura says the transaction is expected to close before the end of the calendar year, subject to customary closing conditions. Until then, the two companies remain separate, and the figures Oura published alongside the announcement are preliminary and unaudited.
The price is the striking part. Counsel had previously disclosed only $36 million in funding, according to STAT, so $625 million is a large multiple of everything the startup had raised. Oura can afford it: the same release reported record growth, with fiscal fourth-quarter revenue (for the quarter ended 30 September 2026) of $533 million, up 153% on the same quarter last year, and full fiscal 2026 revenue of approximately $1.75 billion, up 92%. Adjusted EBITDA for the quarter was $87 million, a 16% margin. Oura's executive chairman David Shuman put it plainly in the release: "our over six million members provides us the confidence to invest $625 million cash to acquire Counsel Health."
| Deal fact | Detail |
|---|---|
| Buyer | Oura (ŌURA), maker of the Oura Ring smart ring |
| Target | Counsel Health, AI-native primary care company |
| Price | $625 million in cash (about ₹5,900 crore), subject to purchase price adjustments |
| Status | Definitive agreement announced 10 Nov 2026; close expected before end of 2026 |
| Counsel's prior funding | $36 million disclosed (per STAT) |
| Oura's scale | Over 6 million members; FY2026 revenue ~$1.75 billion, +92% (preliminary, unaudited) |
Oura Counsel Health acquisition explained: how the doctor-in-the-app works
The deal is not about a new ring. It is about what happens after the ring spots something. Today, Oura tells you your sleep was poor, your heart rate is elevated or your readiness score has dropped — and then leaves the next step to you. Counsel is meant to close that gap.
Here is how Oura describes the flow. A member starts from an Oura insight, or opens a chat with Counsel's medical AI directly. The AI draws on the member's connected medical records, previous interactions, evidence-based clinical guidelines and continuous biometric data from the ring. At any point in the chat, the member can bring in a board-certified Counsel physician, who can diagnose, prescribe and refer as appropriate — all within the Oura app. Oura says the handover to a doctor happens "within minutes".
Behind the chat sits what Counsel calls a clinical AI harness: specialised agents handle tasks such as taking a medical history, retrieving guidelines, reviewing records and detecting emergencies. Each agent is evaluated for performance, safety and quality, and improved using feedback from Counsel's physicians. On the physician side, a tool called the Clinician Cockpit synthesises a patient's medical record and long-term health trends to give the doctor context before they respond. Counsel's founder and CEO, Muthu Alagappan, MD, stresses the guardrail: the company has "built medical AI around trust, safety and responsibility, keeping physicians in the loop for clinical decisions."
That framing matters, because the obvious question is whether an AI is making medical decisions. Oura and Counsel say no: the AI prepares, triages and advises, and a human physician decides. The ring itself, Oura notes in the release, is not a medical device and is not intended to diagnose, treat, cure, monitor or prevent medical conditions. The doctor, not the device, does the diagnosing.
Oura Rings on display at an electronics retailer in Nagoya, Japan. The Oura Ring 5 launched in India in October 2026. Image: Wikimedia Commons / Kyu3a, CC BY-SA 4.0
Why Oura is spending $625 million
Three things make this deal different from a routine acquisition. First, it is a bet on a business model, not a feature. Oura's CEO, Tom Hale, described the goal as "a 24-7 doctor in your pocket" — turning a one-off hardware sale plus a ₹599-a-month membership into an ongoing care relationship. A ring that only reports data is easy to put down; a ring that connects you to a doctor is harder to cancel. Oura says Counsel also opens enterprise doors: Counsel already serves health plans, health systems, employers and digital health companies, and will keep serving those partners after the deal, which Oura says could reach "millions of people beyond our existing member base".
Second, the two companies were already working together, so this is a tested relationship rather than a blind bet. Oura and Counsel first partnered in May 2026 to give Oura members online access to physicians, and in September 2026 Counsel joined the US federal CMS ACCESS model — a ten-year chronic-care programme — with Oura as its preferred wearable partner. Under that programme, from early 2027 Counsel will offer no-cost chronic care management to eligible US Medicare beneficiaries with conditions such as hypertension, obesity, high cholesterol and prediabetes. In the first nine weeks of the partnership, 36,000 Oura members completed onboarding to Counsel's services, and 70% were satisfied with the experience, according to Fierce Healthcare.
Third, the timing follows a change of plan. Oura filed confidentially for a US stock-market listing in May 2026, then delayed its IPO plans just over a month ago because of market uncertainty, according to STAT. The company last raised money in December 2024 — $200 million at a reported $5.2 billion valuation — and has now chosen to spend a large sum of cash on growth instead of going public. It is the latest step in a steady acquisition run: Oura bought the metabolic-health firm Veri and the analytics company Sparta Science in 2024, gesture-technology firm Doublepoint in March 2026 and the AI health companion Galen AI in April 2026. Counsel is the biggest and most clinical of the lot.
Oura is not the only buyer paying up for scale this month: Varonis's $6.3 billion Proofpoint acquisition was agreed on similar logic — buy the capability, integrate it, and sell the combined platform. The difference is that Oura is buying its way into regulated healthcare, where trust is harder to acquire than technology.
What it means for India readers
The honest answer is: the ring is here, the doctor is not — yet. Oura Ring 5 went on sale in India on 22 October 2026, with pre-orders through Amazon and Croma at ₹39,900 for the Silver and Black finishes and ₹50,900 for Gold, Deep Rose, Stealth and Brushed Silver, plus a ₹599-a-month membership. The older Oura Ring 4 has been sold in India since March 2026 at ₹28,900. Indian buyers therefore already own the hardware this deal is built around.
But Counsel's service, as described in the announcement, is built for the US system: health plans, health systems, employers and the Medicare ACCESS programme. Oura has announced nothing about bringing Counsel's doctors to India, and Indian regulations for teleconsultation and AI-assisted care are different from America's. So an Indian Oura Ring 5 owner gets the same sleep, readiness and Health Radar insights as anyone else — but not, for now, the in-app doctor chat that this $625 million is paying for.
There is still a reason to watch it from India. Wearables are racing in the same direction: Meta's Muse AI agent reached the Apple Watch this week, and the industry's big question is no longer who tracks health best, but who turns tracking into care. If Oura proves that ring data plus a doctor keeps members healthier — and paying — rivals will follow, including in India. The test to watch is whether Oura publishes real health outcomes from the Counsel integration, not just satisfaction scores, and whether the service ever gets a launch date outside the US.
Should you care?
✅ Verdict: If you own an Oura Ring outside the US, this is a "watch and wait" story — the deal is real and large, but the doctor service is not coming to you yet. If you are in the US, or you follow wearables as a business, it is the most important Oura news of the year: a tracker company just spent $625 million to become a care company. The open question is whether AI-plus-doctor care inside an app earns trust at scale — and whether Oura can prove it with outcomes, not just growth numbers.
FAQs
Why did Oura buy Counsel Health?
To turn the Oura Ring from a tracker into a care service. Counsel's medical AI and physicians let members go from a health insight to advice, a diagnosis or a prescription inside the Oura app, instead of the ring only reporting a problem. Oura also gains Counsel's enterprise customers — health plans, health systems and employers — beyond its own member base.
How much did Oura pay for Counsel Health?
$625 million in cash — about ₹5,900 crore — under a definitive agreement announced on 10 November 2026. The price is subject to purchase price adjustments, and the deal is expected to close before the end of 2026. Counsel had previously disclosed only $36 million in funding.
Will Oura Ring owners get access to a doctor now?
Not immediately, and not everywhere. The deal has been announced but has not closed yet, and Counsel's service is currently built around US health plans, employers and the Medicare ACCESS programme. US members already using Counsel can chat with the medical AI and reach a board-certified physician within minutes in the app; availability elsewhere has not been announced.
What does the Oura Counsel Health deal mean for India?
For now, very little changes for Indian owners: the Oura Ring 5 is on sale in India from ₹39,900 with a ₹599-a-month membership, and the ring's tracking and insights work the same. But the doctor service has no India launch date, so Indian owners cannot yet use the in-app consultations this deal is about. The deal still matters as a signal — it shows where wearables are heading, from tracking health to delivering care.
Takeaway
Oura's $625 million Counsel Health deal is the smart-ring industry's clearest move yet from measuring health to treating it. The numbers behind it are strong — record revenue, six million members, high satisfaction — but the deal is announced, not closed, the financials are preliminary, and the doctor service is US-only for now. Indian readers should keep the ring, and keep an eye on whether the care ever follows it here.
If you own an Oura Ring, the next step is the one Oura itself links to this story: check what your ring already offers. Read our Oura Ring 5 India price and specs explainer to see the full cost of the ring plus membership, and what its Health Radar can — and cannot — tell you.
Sources
- Oura to Acquire Counsel Health — Oura press release (Business Wire), 10 November 2026
- Smart ring maker Oura to acquire Counsel Health for $625 million — Reuters, 10 November 2026
- Oura to acquire Counsel Health for $625 million, a big bet on AI care — STAT, 10 November 2026
- Counsel Health taps Oura to join CMS ACCESS model — Fierce Healthcare, September 2026
- Oura Ring 5 launches in India, price starts at Rs 39,900 — Times of India, 22 October 2026
Comments
Post a Comment